Lexicon Pharma (LXRX) Tops Q1 EPS by 1c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.55 +11.35%
EPS Growth %: -600.0%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -600.0%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $9.22 million versus the consensus estimate of $13.27 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- BMO Capital Reiterates Outperform Rating on CMS Energy (CMS)
- Apple’s big price hike seen as "an unprecedented push to protect margins"
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
